Christmas & New Year Discount Image

North America Transcriptomics Market 2021-2031 by Component (Instruments, Consumables, Software, Services), Technology (PCR, Next-Generation Sequencing, Microarray, ISH, Gene Regulation, Others), Application (Drug Discovery and Development, Diagnostics, Single Cell Analysis, Gene Expression, Cell Biology, Others), End User (Academic and Research Institutions, Biotech and Biopharma Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity

North America transcriptomics market is projected to grow by 10.3% annually in the forecast period and reach $6,124.0 million by 2031, driven by the surging demand for personalized medicine, the high demand for diagnostic of inflammatory diseases such as COVID-19, the decrease in the cost of sequencing, the rising application of next-generation sequencing and RNA sequencing in transcriptomics, and the advancement of products launches along with increasing R&D expenditure.
Highlighted with 32 tables and 43 figures, this 114-page report “North America Transcriptomics Market 2021-2031 by Component (Instruments, Consumables, Software, Services), Technology (PCR, Next-Generation Sequencing, Microarray, ISH, Gene Regulation, Others), Application (Drug Discovery and Development, Diagnostics, Single Cell Analysis, Gene Expression, Cell Biology, Others), End User (Academic and Research Institutions, Biotech and Biopharma Companies, CROs, Others), and Country: Trend Forecast and Growth Opportunity” is based on a comprehensive research of the entire North America transcriptomics market and all its sub-segments through extensively detailed classifications. Profound analysis and assessment are generated from premium primary and secondary information sources with inputs derived from industry professionals across the value chain. The report is based on studies on 2019-2021 and provides forecast from 2022 till 2031 with 2021 as the base year. (Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)

In-depth qualitative analyses include identification and investigation of the following aspects:
• Market Structure
• Growth Drivers
• Restraints and Challenges
• Emerging Product Trends & Market Opportunities
• Porter’s Fiver Forces
The trend and outlook of North America market is forecast in optimistic, balanced, and conservative view by taking into account of COVID-19 and Russia-Ukraine conflict. The balanced (most likely) projection is used to quantify North America transcriptomics market in every aspect of the classification from perspectives of Component, Technology, Application, End User, and Country.

Based on Component, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Instruments
• Consumables
• Software
• Services

Based on Technology, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Polymerase Chain Reaction (PCR)
• Next-Generation Sequencing
• Microarray
• In-Situ Hybridization (ISH)
• Gene Regulation Technologies
• Other Technologies

By Application, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Drug Discovery and Development
• Diagnostics
• Single Cell Analysis
• Gene Expression
• Cell Biology
• Other Applications

By End User, the North America market is segmented into the following sub-markets with annual revenue ($ mn) for 2021-2031 included in each section.
• Academic and Research Institutions
• Biotechnology and Biopharmaceutical Companies
• Contract Research Organizations (CROs)
• Other End Users

Geographically, the following national/local markets are fully investigated:
• U.S.
• Canada
• Mexico
For each key country, detailed analysis and data for annual revenue ($ mn) are available for 2021-2031. The breakdown of national markets by Component, Technology and Application over the forecast years are also included.

The report also covers current competitive scenario and the predicted trend; and profiles key vendors including market leaders and important emerging players.
Selected Key Players:
10x Genomics
Agilent Technologies, Inc.
ANGLE plc
Becton, Dickinson and Company (BD)
Bio-Rad Laboratories, Inc.
BioSypder, Inc.
Bio-Techne
Cytiva
F. Hoffmann-La Roche Ltd.
Fluidigm Corporation
GE Healthcare
Illumina, Inc.
Menarini Silicon Biosystems
Merck & Co., Inc.
NanoString
Pacific Biosciences of California, Inc.
PerkinElmer Inc.
Promega Corporation
Qiagen N. V.
Takara Bio Inc.
Thermo Fisher Scientific Inc.
(Please note: The report will be updated before delivery so that the latest historical year is the base year and the forecast covers at least 5 years over the base year.)
1 Introduction 7
1.1 Industry Definition and Research Scope 7
1.1.1 Industry Definition 7
1.1.2 Research Scope 9
1.2 Research Methodology 12
1.2.1 Overview of Market Research Methodology 12
1.2.2 Market Assumption 13
1.2.3 Secondary Data 13
1.2.4 Primary Data 13
1.2.5 Data Filtration and Model Design 14
1.2.6 Market Size/Share Estimation 15
1.2.7 Research Limitations 16
1.3 Executive Summary 17
2 Market Overview and Dynamics 20
2.1 Market Size and Forecast 20
2.1.1 Impact of COVID-19 on World Economy 21
2.1.2 Impact of COVID-19 on the Market 23
2.2 Major Growth Drivers 25
2.3 Market Restraints and Challenges 30
2.4 Emerging Opportunities and Market Trends 33
2.5 Porter’s Fiver Forces Analysis 37
3 Segmentation of North America Market by Component 41
3.1 Market Overview by Component 41
3.2 Instruments 43
3.3 Consumables 45
3.4 Software 47
3.5 Services 49
4 Segmentation of North America Market by Technology 50
4.1 Market Overview by Technology 50
4.2 Polymerase Chain Reaction (PCR) 52
4.3 Next-Generation Sequencing 54
4.4 Microarray 56
4.5 In-Situ Hybridization (ISH) 58
4.6 Gene Regulation Technologies 60
4.7 Other Technologies 61
5 Segmentation of North America Market by Application 62
5.1 Market Overview by Application 62
5.2 Drug Discovery and Development 64
5.3 Diagnostics 65
5.4 Single Cell Analysis 66
5.5 Gene Expression 67
5.6 Cell Biology 68
5.7 Other Applications 69
6 Segmentation of North America Market by End User 70
6.1 Market Overview by End User 70
6.2 Academic and Research Institutions 72
6.3 Biotechnology and Biopharmaceutical Companies 73
6.4 Contract Research Organizations (CROs) 74
6.5 Other End Users 75
7 North America Market 2021-2031 by Country 76
7.1 Overview of North America Market 76
7.2 U.S. 79
7.3 Canada 82
7.4 Mexico 84
8 Competitive Landscape 86
8.1 Overview of Key Vendors 86
8.2 New Product Launch, Partnership, Investment, and M&A 91
8.3 Company Profiles 92
10x Genomics 92
Agilent Technologies, Inc. 94
ANGLE plc 95
Becton, Dickinson and Company (BD) 96
Bio-Rad Laboratories, Inc. 97
BioSypder, Inc. 98
Bio-Techne 99
Cytiva 100
F. Hoffmann-La Roche Ltd. 101
Fluidigm Corporation 102
GE Healthcare 103
Illumina, Inc. 104
Menarini Silicon Biosystems 105
Merck & Co., Inc. 106
NanoString 107
Pacific Biosciences of California, Inc. 108
PerkinElmer Inc. 109
Promega Corporation 110
Qiagen N. V. 111
Takara Bio Inc. 112
Thermo Fisher Scientific Inc. 113
RELATED REPORTS 114

no record found

Report Price

  • Single User $ 2500.00
  • Multi User $ 3600.00
  • Enterprise $ 4700.00